These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5304276)

  • 1. Establishment of a clone of BHK-21 cells favorable to rubella hemagglutinin production.
    Kono S; Kohase M; Suganuma M
    Jpn J Med Sci Biol; 1968 Aug; 21(4):289-93. PubMed ID: 5304276
    [No Abstract]   [Full Text] [Related]  

  • 2. Rubella haemagglutinin prepared in BS-C-1 cells.
    Rafajko RR; zur Nedden D
    Nature; 1968 Dec; 220(5174):1347-9. PubMed ID: 4973536
    [No Abstract]   [Full Text] [Related]  

  • 3. An attenuated rubella virus vaccine (Cendehill 51 strain) grown in primary rabbit kidney cells.
    Huygelen C; Peetermans J; Prinzie A
    Prog Med Virol; 1969; 11():107-25. PubMed ID: 4984707
    [No Abstract]   [Full Text] [Related]  

  • 4. A micro tissue culture test for the titration and neutralization of rubella virus.
    Furesz J; Moreau P; Yarosh W
    Can J Microbiol; 1969 Jan; 15(1):67-71. PubMed ID: 5765179
    [No Abstract]   [Full Text] [Related]  

  • 5. Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.
    Liebhaber H
    J Immunol; 1970 Apr; 104(4):818-25. PubMed ID: 5462589
    [No Abstract]   [Full Text] [Related]  

  • 6. Rubella hemagglutinin prepared in serum free suspension culture of BHK-21 cells.
    Halonen PE; Stewart JA; Hall AD
    Ann Med Exp Biol Fenn; 1967; 45(2):182-5. PubMed ID: 6049273
    [No Abstract]   [Full Text] [Related]  

  • 7. Rubella precipitin response in natural infection and in vaccination.
    Paul NR; Rhodes AJ; Campbell JB; Labzoffsky NA
    Arch Gesamte Virusforsch; 1974; 45(4):335-51. PubMed ID: 4216341
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic stability in humans of the rabbit immunogenic marker of Cendehill rubella vaccine virus.
    Gill SD; Furesz J
    Arch Gesamte Virusforsch; 1973; 43(1):135-43. PubMed ID: 4793528
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for a rubella virus vaccine.
    Parkman PD; Meyer HM
    Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711
    [No Abstract]   [Full Text] [Related]  

  • 10. Attenuation of rubella virus by serial passage in primary rabbit kidney cell cultures. II. Experiments in animals.
    Huygelen C; Peetermans J
    Arch Gesamte Virusforsch; 1967; 21(3):357-65. PubMed ID: 4971492
    [No Abstract]   [Full Text] [Related]  

  • 11. Precipitinogens of rubella virus-infected cells.
    Le Bouvier GL
    Proc Soc Exp Biol Med; 1969 Jan; 130(1):51-4. PubMed ID: 4973872
    [No Abstract]   [Full Text] [Related]  

  • 12. The hemagglutination inhibition test for rubella: a comparison of its sensitivity to that of neutralization, complement fixation and fluorescent antibody tests for diagnosis of infection and determination of immunity status.
    Lennette EH; Schmidt NJ; Magoffin RL
    J Immunol; 1967 Oct; 99(4):785-93. PubMed ID: 4860926
    [No Abstract]   [Full Text] [Related]  

  • 13. Rubella hemagglutinin prepared in a serial line African green monkey kidney cells.
    Rafajko RR; zur Nedden D
    Appl Microbiol; 1968 May; 16(5):803-4. PubMed ID: 4969859
    [No Abstract]   [Full Text] [Related]  

  • 14. An attenuated rubella virus strain adapted to primary rabbit kidney.
    Plotkin SA; Farquhar J; Katz M; Prinzie A; Ongalls TH
    Am J Epidemiol; 1968 Jul; 88(1):97-102. PubMed ID: 5661538
    [No Abstract]   [Full Text] [Related]  

  • 15. Demonstration by immunoelectro-osmophoresis of precipitating antibodies to a purified rubella virus antigen.
    Grauballe PC; Vestergaard BF; Hornsleth A; Leerhoy J; Johnsson T
    Infect Immun; 1975 Jul; 12(1):55-61. PubMed ID: 1140852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rubella in pregnancy.
    Maidman JE; Paton JB
    Obstet Gynecol Annu; 1974; 3(0):345-75. PubMed ID: 4608493
    [No Abstract]   [Full Text] [Related]  

  • 17. Complement-fixing and fluorescent antibody responses to an attenuated Rubella virus vaccine.
    Schmidt NJ; Lennette EH
    Am J Epidemiol; 1970 Apr; 91(4):351-4. PubMed ID: 4912184
    [No Abstract]   [Full Text] [Related]  

  • 18. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.
    Vesikari T; Vaheri A; Leinikki P
    Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281
    [No Abstract]   [Full Text] [Related]  

  • 19. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemagglutination inhibiting antibodies of Rubella virus in a sample of female population in the Province of Modena].
    Aggazzotti-Zanasi G; Manicardi G; Quaglio-Fabio GP
    Nuovi Ann Ig Microbiol; 1975; 26(1):1-6. PubMed ID: 1197020
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.